Author:
Kamat Ashish M.,Gontero Paolo,Palou Joan
Subject
Urology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery
Reference30 articles.
1. Definitions, end points, and clinical trial designs for non-muscle-invasive bladder cancer: recommendations from the International Bladder Cancer Group;Kamat;J Clin Oncol,2016
2. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016;Babjuk;Eur Urol,2017
3. EAU Panel on NMIBC. European Association of Urology (EAU) guidelines on non-muscle-invasive bladder cancer (NMIBC), TaT1 and carcinoma in situ (CIS): 2019 update;Babjuk,2019
4. FDA. FDA definition of BCG-unresponsive disease. https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM529600.pdf.
5. Management of stage T1 tumors of the bladder: International Consensus Panel;Nieder;Urology,2005
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献